- Home
- XPEV vs PODD Comparison
XPEV vs PODD Comparison
Compare XPEV & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEV | PODD |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 22.1B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | XPEV | PODD |
|---|---|---|
| Price | $20.49 | $293.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 19 |
| Target Price | $24.91 | ★ $366.58 |
| AVG Volume (30 Days) | ★ 7.6M | 641.0K |
| Earning Date | 11-17-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.45 |
| Revenue | ★ $9,912,782,208.00 | $2,521,800,000.00 |
| Revenue This Year | $95.09 | $32.55 |
| Revenue Next Year | $38.02 | $20.50 |
| P/E Ratio | ★ N/A | $86.70 |
| Revenue Growth | ★ 86.64 | 27.11 |
| 52 Week Low | $11.61 | $230.05 |
| 52 Week High | $28.24 | $354.88 |
Technical Indicators
Market Signals| Indicator | XPEV | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 47.01 |
| Support Level | $19.86 | $278.79 |
| Resistance Level | $20.67 | $299.80 |
| Average True Range (ATR) | 0.62 | 6.27 |
| MACD | 0.16 | 1.97 |
| Stochastic Oscillator | 62.80 | 68.60 |
Price Performance
Historical ComparisonAbout XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.